Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Amgen Inc

AMGN
Current price
333.24 USD -1.12 USD (-0.33%)
Last closed 335.97 USD
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NASDAQ
Capitalization 180 226 064 384 USD
Yield for 12 month +41.55 %
1Y
3Y
5Y
10Y
15Y
AMGN
21.11.2021 - 28.11.2021

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. Address: One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

320.24 USD

P/E ratio

48.0644

Dividend Yield

2.68 %

Current Year

+28 190 000 000 USD

Last Year

+26 323 000 000 USD

Current Quarter

+7 396 000 000 USD

Last Quarter

+8 196 000 000 USD

Current Year

+19 739 000 000 USD

Last Year

+19 917 000 000 USD

Current Quarter

+4 196 000 000 USD

Last Quarter

+5 084 000 000 USD

Key Figures AMGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 11 658 000 384 USD
Operating Margin TTM 13.33 %
PE Ratio 48.0644
Return On Assets TTM 4.88 %
PEG Ratio 2.3869
Return On Equity TTM 72.57 %
Wall Street Target Price 320.24 USD
Revenue TTM 29 532 000 256 USD
Book Value 9.36 USD
Revenue Per Share TTM
Dividend Share 8.64 USD
Quarterly Revenue Growth YOY 22 %
Dividend Yield 2.68 %
Gross Profit TTM 19 917 000 000 USD
Earnings per share 6.99 USD
Diluted Eps TTM 6.99 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -52.4 %
Profit Margin 12.74 %

Dividend Analytics AMGN

Champion - 10+ consecutive years of dividend increases

Dividend growth over 5 years

61 %

Continuous growth

12 years

Payout Ratio 5 years average

58 %

Dividend History AMGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 9
Ex Dividend Date 16.05.2024
Forward Annual Dividend Yield 2.68 %
Last Split Factor 2:1
Payout Ratio 47.02 %
Last Split Date 22.11.1999
Dividend Date 07.06.2024

Stock Valuation AMGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 48.0644
Forward PE 13.7741
Enterprise Value Revenue 6.986
Price Sales TTM 5.0812
Enterprise Value EBITDA 13.3056
Price Book MRQ 22.989

Financials AMGN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AMGN

For 52 weeks

221.3 USD 338.98 USD
50 Day MA 312.56 USD
Shares Short Prior Month 9 124 139
200 Day MA 289.2 USD
Short Ratio 3.44
Shares Short 8 984 675
Short Percent 1.68 %

Dynamics of changes in the value of assets

0

0939

5.48 HKD China Construction Bank Corp +0.01 (+1.29%)
Detailed analytics
G

GCP

160.50 EUR General Electric Company +11.43 (+7%)
Detailed analytics
INTU

INTU

637.10 USD Intuit Inc -6.58 (-1.02%)
Detailed analytics
A

ABT

103.92 USD Abbott Laboratories -0.09 (-0.09%)
Detailed analytics
6

6MK

115.00 EUR Merck & Co. Inc 0 (0%)
Detailed analytics